ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,910.91
0.18%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Pyxis Oncology Inc (PYXS)

  7. Pyxis Oncology Inc (PYXS) Noticias

PYXS Pyxis Oncology Inc

4.34
-0.17 (-3.77%)
10 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pyxis Oncology Inc PYXS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.17 -3.77% 4.34 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.48 4.31 4.55 4.34 4.51
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202406:30GLOBEPyxis Oncology to Present at the RBC Capital Markets Global..
28/3/202415:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
27/3/202406:30GLOBEPyxis Oncology Obtains $8 Million Payment for the Sale of..
21/3/202406:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
13/3/202407:00GLOBEPyxis Oncology Expands Board of Directors with Appointment..
08/3/202415:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/3/202415:30GLOBEPyxis Oncology to Present at Leerink Global Biopharma..
05/3/202415:45GLOBEPyxis Oncology to Present New PYX-201, PYX-106 and PYX-102..
28/2/202406:02EDGAR2Form 8-K - Current report
27/2/202407:00GLOBEPyxis Oncology Announces $50 Million Private Placement
29/12/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
06/12/202315:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/11/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202306:22EDGAR2Form 8-K - Current report
28/11/202306:00GLOBEPyxis Oncology Announces Appointment of Ken Kobayashi, M.D.,..
17/11/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:44EDGAR2Form 8-K - Current report
07/11/202315:30GLOBEPyxis Oncology Announces Initiatives to Prioritize Lead ADC..
27/10/202315:34EDGAR2Form 8-K/A - Current report: [Amend]
28/9/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202308:18GLOBEPyxis Oncology Announces Four Abstracts Accepted for Poster..
25/9/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202316:08EDGAR2Form 144 - Report of proposed sale of securities
31/8/202315:01GLOBEPyxis Oncology to Participate in Two Upcoming Investment..
24/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
23/8/202316:30EDGAR2Form S-8 POS - Securities to be offered to employees in..
23/8/202316:28EDGAR2Form POS AM - Post-Effective amendments for registration..
23/8/202316:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/8/202307:47EDGAR2Form 8-K - Current report
23/8/202307:35GLOBEPyxis Oncology Successfully Completes Acquisition of..
11/8/202316:00EDGAR2Form 144 - Report of proposed sale of securities
11/8/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:26EDGAR2Form 425 - Prospectuses and communications, business..
11/8/202306:25EDGAR2Form 8-K - Current report
11/8/202306:00GLOBEPyxis Oncology Reports Financial Results for Second-Quarter..
11/8/202305:35EDGAR2Form 425 - Prospectuses and communications, business..
11/8/202305:34EDGAR2Form 8-K - Current report
01/8/202316:14EDGAR2Form 144 - Report of proposed sale of securities
01/8/202315:01GLOBEPyxis Oncology to Present at BTIG Virtual Biotechnology..
31/7/202315:41EDGAR2Form 144 - Report of proposed sale of securities
27/7/202316:02EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
PYXS
Pyxis Oncology
NYSE
FOA
Finance of America Compa...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados